Psychological Disease Clinical Trial
Official title:
RinasciMENTE, An Internet-Based Self-Help Intervention for People With Psychological Distress Due to Coronavirus-19: Study Protocol of a Randomized Controlled Trial
This study aims is the evaluation of the efficacy and feasibility of RinasciMENTE, the Randomized Controlled Clinical Trial compared with a waiting list control group.
Status | Not yet recruiting |
Enrollment | 128 |
Est. completion date | June 1, 2023 |
Est. primary completion date | December 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - 18 years old or over and both gender - Italian mother-tongue - Score 14 or less on Patients Health Questionnaire-9 (PHQ-9) - Internet access and basic informatic ability to navigate the internet platform - Must be able to complete a phone interview Exclusion Criteria: - Having severe and mental impairments, psychiatric condition and neurological disorder - Not be able to use a computer or do not have internet access - Not be able to complete a phone interview - Score 15 or more on PHQ-9 |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Catholic University of the Sacred Heart | Bar-Ilan University, Israel, Istituto Auxologico Italiano, Karolinska Institutet, Linkoeping University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Outcome Questionnaire (OQ-45) | It measures the changes in adult patients thanks to intervention. | Baseline, 2 months follow-up, 12 months follow-up | |
Secondary | Perceived stress scale (PSS) | It evaluates the perceived stress by person | Baseline, 2 months follow-up, 12 months follow-up | |
Secondary | Emotional regulation questionnaire (ERQ) | It measures how respondents regulate their emotions through two dimensions: cognitive revaluation and expressive suppression. | Baseline, 2 months follow-up, 12 months follow-up | |
Secondary | Depression Anxiety Stress Scales-Short Version (DASS-21) | It allows to observe three dimensions (depression, anxiety and stress) | Baseline, 2 months follow-up, 12 months follow-up | |
Secondary | Fear of COVID-19 Scale (FCV-19S) | It evaluates how subjects show fear relative to the recent pandemic of Coronavirus | Baseline, 2 months follow-up, 12 months follow-up | |
Secondary | General Self-efficacy Scale (GSES) | It evaluates the confidence of subjects in their ability to cope with a variety of difficult or stressing situations. | Baseline, 2 months follow-up, 12 months follow-up | |
Secondary | World Health Organization Quality of Life (WHOQOL)-BREF | It detects four dimensions of quality of life: physical health, psychological health, social relations and environment. | Baseline, 2 months follow-up, 12 months follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05153109 -
Reliabilty and Validity of a Diagnostic Interview for Parents of Babies and Preescholers
|
||
Completed |
NCT04475055 -
Reliability and Validity of the DIPS (Structured Interview) in a Community Sample
|
||
Completed |
NCT04450238 -
The Dual Factor Model of Mental Health in Inpatients
|
||
Completed |
NCT04453475 -
Feasibility and Benefits of Digital Services During the COVID19 Pandemic
|
N/A | |
Recruiting |
NCT06011642 -
Reliability and Validity of a Digital Version of a Structured Interview for Children and Adolescents (Kinder-eDIPS)
|
||
Completed |
NCT05238415 -
ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19
|
N/A |